BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16857328)

  • 1. Cognitive function in late versus early postmenopausal stage.
    Elsabagh S; Hartley DE; File SE
    Maturitas; 2007 Jan; 56(1):84-93. PubMed ID: 16857328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE
    J Psychopharmacol; 2005 Mar; 19(2):173-81. PubMed ID: 15728439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No differences in performance on test of working memory and executive functioning between healthy elderly postmenopausal women using or not using hormone therapy.
    Grigorova M; Sherwin BB
    Climacteric; 2006 Jun; 9(3):181-94. PubMed ID: 16766432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trough oestradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants.
    File SE; Heard JE; Rymer J
    Psychopharmacology (Berl); 2002 Apr; 161(1):107-12. PubMed ID: 11967638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot flashes and estrogen therapy do not influence cognition in early menopausal women.
    LeBlanc ES; Neiss MB; Carello PE; Samuels MH; Janowsky JS
    Menopause; 2007; 14(2):191-202. PubMed ID: 17194963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated postmenopausal cognitive decline is restricted to women with normal BMI: longitudinal evidence from the Betula project.
    Thilers PP; Macdonald SW; Nilsson LG; Herlitz A
    Psychoneuroendocrinology; 2010 May; 35(4):516-24. PubMed ID: 19811879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN).
    Luetters C; Huang MH; Seeman T; Buckwalter G; Meyer PM; Avis NE; Sternfeld B; Johnston JM; Greendale GA
    J Womens Health (Larchmt); 2007 Apr; 16(3):331-44. PubMed ID: 17439378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of serum oestradiol level, age, and education with cognitive performance in peri- and late postmenopausal women.
    Tuomisto H; Salo P; Saarinen R; Kalleinen N; Polo-Kantola P
    Maturitas; 2012 Feb; 71(2):173-9. PubMed ID: 22197594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function in postmenopausal women treated with raloxifene.
    Yaffe K; Krueger K; Sarkar S; Grady D; Barrett-Connor E; Cox DA; Nickelsen T;
    N Engl J Med; 2001 Apr; 344(16):1207-13. PubMed ID: 11309635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study.
    MacLennan AH; Henderson VW; Paine BJ; Mathias J; Ramsay EN; Ryan P; Stocks NP; Taylor AW
    Menopause; 2006; 13(1):28-36. PubMed ID: 16607096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased urinary cortisol levels during the menopausal transition.
    Woods NF; Carr MC; Tao EY; Taylor HJ; Mitchell ES
    Menopause; 2006; 13(2):212-21. PubMed ID: 16645535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and cognition: effects of timing and treatment type.
    Khoo SK; O'Neill S; Byrne G; King R; Travers C; Tripcony L
    Climacteric; 2010 Jun; 13(3):259-64. PubMed ID: 19886816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and cognitive function in postmenopausal women.
    Kurt M; Bekçi B; Karakaş S
    Maturitas; 2006 Jan; 53(1):39-48. PubMed ID: 16325023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep and the menopause - do postmenopausal women experience worse sleep than premenopausal women?
    Kalleinen N; Polo-Kantola P; Himanen SL; Alhola P; Joutsen A; Urrila AS; Polo O
    Menopause Int; 2008 Sep; 14(3):97-104. PubMed ID: 18714074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonepisodic memory deficits in amnestic MCI.
    Economou A; Papageorgiou SG; Karageorgiou C; Vassilopoulos D
    Cogn Behav Neurol; 2007 Jun; 20(2):99-106. PubMed ID: 17558253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous estrogen is not associated with cognitive performance before, during, or after menopause.
    Herlitz A; Thilers P; Habib R
    Menopause; 2007; 14(3 Pt 1):425-31. PubMed ID: 17279058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical, vegetative and cognitive disorders in hypertensive postmenopausal women in relation to menopause causes].
    Kolbasnikov SV; Bakhareva ON
    Ter Arkh; 2006; 78(10):64-7. PubMed ID: 17180942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does hormone therapy affect attention and memory in sleep-deprived women?
    Alhola P; Kylmälä M; Urrila AS; Karakorpi M; Portin R; Kalleinen N; Polo-Kantola P
    Climacteric; 2008 Jun; 11(3):221-32. PubMed ID: 18568787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.